- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01187680
Efficacy of Sprayable PEG Barrier in Gynecologic Laparoscopy
December 28, 2010 updated by: Radboud University Medical Center
Polyethylene Glycol Adhesion Barrier Reduces Adhesions After Gynecologic Laparoscopy; a Prospective Randomized Controlled Pilot Study
The purpose of the study is to investigate whether sprayable PEG barrier is effective in reducing adhesions in laparoscopic gynecologic surgery.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
16
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Noord-Holland
-
Amsterdam, Noord-Holland, Netherlands
- Onze Lieve Vrouwe Gasthuis
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- >18 years
- Undergoing gynecologic laparoscopy
Exclusion Criteria:
- Suspected malignancy
- Incomplete adhesiolysis during initial laparoscopy
- Pregnancy
- Lactating
- Stage IV endometriosis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control
|
Good surgical technique, no adhesion barrier
|
|
Experimental: Spraygel
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
|---|---|
|
successful adhesion prevention
|
Adhesion prevention was defined as successful if no de novo fromed adhesion were found at second look laparoscopy.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
|---|---|
|
LABS adhesion score
|
|
|
Adhesion sites
|
Reduction in the number of sites covered with adhesions
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2002
Primary Completion (Actual)
April 1, 2004
Study Completion (Actual)
July 1, 2009
Study Registration Dates
First Submitted
July 19, 2010
First Submitted That Met QC Criteria
August 23, 2010
First Posted (Estimate)
August 24, 2010
Study Record Updates
Last Update Posted (Estimate)
December 29, 2010
Last Update Submitted That Met QC Criteria
December 28, 2010
Last Verified
August 1, 2010
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RU-RTB-0002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postoperative Adhesion
-
Medy-ToxCompletedPostoperative Adhesion of UterusKorea, Republic of
-
Bucheon St. Mary's HospitalCompletedProstate Cancer | Postoperative Adhesion
-
University Medical Center NijmegenUnknownPostoperative AdhesionsNetherlands
-
Eio Biomedical Ltd.CompletedReduction of Postoperative AdhesionsLithuania
-
Ain Shams UniversityNot yet recruiting
-
Amsterdam UMC, location VUmcCompletedAdhesions Pelvic | Adhesion; Uterus | Adhesion; BladderNetherlands
-
Hua DuanRecruitingIntrauterine Adhesion | Database for Intrauterine Adhesion | Risk Factors for Intrauterine Adhesion | Risk Stratification and Prognostic AssessmentChina
-
Rocket Pharmaceuticals Inc.California Institute for Regenerative Medicine (CIRM)CompletedLeukocyte Adhesion Defect - Type ISpain, United States, United Kingdom
-
Rocket Pharmaceuticals Inc.WithdrawnLeukocyte Adhesion Defect - Type ISpain
-
Limin FengRecruitingIntrauterine AdhesionChina